This trial tests a new breast implant called REGENERA in women aged 40–70 who are having a lumpectomy for early-stage breast cancer. The implant is placed during the same surgery to fill the gap left by the removed tumor. The study aims to see if the implant is safe and whether s…
Phase: NA • Sponsor: Tensive SRL • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC